amantadine has been researched along with Cardiovascular Diseases in 6 studies
amant: an antiviral compound consisting of an adamantane derivative chemically linked to a water-solube polyanioic matrix; structure in first source
Cardiovascular Diseases: Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Amantadine prophylaxis was performed in 91 patients during influenza A epidemics." | 1.29 | [Amantadine in the prevention of nosocomial influenza]. ( Bíró, L; Guller, Z; Koltai, M; Szepesi, A, 1996) |
| "The drug treatment of Parkinson's disease should be tailored to the age of the patient, coexistence of dementia or postural hypotension, duration of the disease process and the emergence of side effects." | 1.27 | The drug treatment of Parkinson's disease. ( Morris, JG, 1984) |
| " Changes include addition of statements about the route of vaccine administration; the use of amantadine in medical personnel during influenza A outbreaks; the need to prepare contingency plans to expedite use of amantadine in aborting influenza A outbreaks among residents of institutions; and reduction in the dosage of amantadine for older patients or persons with seizure disorders." | 1.27 | Prevention and control of influenza. Recommendation of the Immunization Practices Advisory Committee. Centers for Disease Control, Department of Health and Human Services. ( , 1985) |
| "Amantadine has been used since 1969 in the treatment of Parkinson's disease." | 1.26 | [Circulatory disorders induced by amantidine]. ( Cloarec, M; Contamin, F; Debray, J; Graisely, B; Mignot, B; Singer, B, 1976) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (66.67) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pagonabarraga, J | 1 |
| Kulisevsky, J | 1 |
| Morris, JG | 1 |
| Bíró, L | 1 |
| Guller, Z | 1 |
| Koltai, M | 1 |
| Szepesi, A | 1 |
| Cloarec, M | 1 |
| Singer, B | 1 |
| Mignot, B | 1 |
| Contamin, F | 1 |
| Graisely, B | 1 |
| Debray, J | 1 |
| Ngai, SH | 1 |
2 reviews available for amantadine and Cardiovascular Diseases
| Article | Year |
|---|---|
[Dopaminergic treatment in Parkinson's disease: what has each therapeutic family got to offer?].
Topics: Amantadine; Antiparkinson Agents; Cardiovascular Diseases; Catechol O-Methyltransferase; Catechol O- | 2014 |
Parkinsonism, levodopa, and anesthesia.
Topics: Amantadine; Anesthesia; Animals; Apomorphine; Benperidol; Blood-Brain Barrier; Brain; Cardiovascular | 1972 |
4 other studies available for amantadine and Cardiovascular Diseases
| Article | Year |
|---|---|
The drug treatment of Parkinson's disease.
Topics: Amantadine; Bromocriptine; Cardiovascular Diseases; Chemical Phenomena; Chemistry; Drug Therapy, Com | 1984 |
[Amantadine in the prevention of nosocomial influenza].
Topics: Aged; Amantadine; Antiviral Agents; Cardiovascular Diseases; Chronic Disease; Cross Infection; Diabe | 1996 |
[Circulatory disorders induced by amantidine].
Topics: Aged; Amantadine; Capillaries; Cardiovascular Diseases; Endoscopy; Female; Humans; Male; Microcircul | 1976 |
Prevention and control of influenza. Recommendation of the Immunization Practices Advisory Committee. Centers for Disease Control, Department of Health and Human Services.
Topics: Adolescent; Adult; Aged; Amantadine; Bacterial Vaccines; Cardiovascular Diseases; Centers for Diseas | 1985 |